JD Health International (HKG:6618) recorded a profit attributable to the owners of 4.16 billion yuan in 2024, 94% higher than 2.14 billion yuan from 2023, a Thursday Hong Kong bourse filing said.
The earnings per share were 1.32 yuan, compared with 0.68 yuan per share from a year earlier.
The digital health services company's revenue for the year came in at 58.2 billion yuan, 8.6% higher than 53.5 billion yuan of the preceding year.
The increase in revenue is attributed to an increase in revenue from the sales of pharmaceutical and healthcare products resulting from an increase in active user accounts, additional purchases, and the increase in online product sales.
Comments